menu
    • menu

    Company profile for Repligen Corporation

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Repligen is a bioprocessing-focused life sciences company bringing over 35 years of expertise and innovation to our customers. We are inspiring advances in bioprocessing through the development and commercialization of high-value products and flexible solutions that address critical steps in the production of biologic drugs, principally monoclonal antibodies. Our manufacturing facilities are located at our Waltham, Massachu...
    Repligen is a bioprocessing-focused life sciences company bringing over 35 years of expertise and innovation to our customers. We are inspiring advances in bioprocessing through the development and commercialization of high-value products and flexible solutions that address critical steps in the production of biologic drugs, principally monoclonal antibodies. Our manufacturing facilities are located at our Waltham, Massachusetts headquarters in the USA, and in Lund, Sweden, Weingarten, Germany , Rancho Dominguez, CA and Shrewsbury, MA. We market our products globally through a direct commercial organization in the U.S., Europe

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Repligen CorporationUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    41 Seyon Street Building 1, Suite 100 Waltham, Massachusetts 02453
    Telephone
    Telephone
    781.250.0111
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.repligen.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/repligen-corporation/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/repligen

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Repligen To Report First Quarter 2026 Financial Results
    Repligen To Report First Quarter 2026 Financial Results

    22 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/22/3278845/24603/en/repligen-to-report-first-quarter-2026-financial-results.html

    GLOBENEWSWIRE
    22 Apr 2026
    Share Share
    Repligen Corporation To Present At Upcoming March Conferences
    Repligen Corporation To Present At Upcoming March Conferences

    05 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/05/3250046/24603/en/Repligen-Corporation-to-Present-at-Upcoming-March-Conferences.html

    GLOBENEWSWIRE
    05 Mar 2026
    Share Share
    Repligen Unveils 2025 Financials, Offers 2026 Guidance
    Repligen Unveils 2025 Financials, Offers 2026 Guidance

    24 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/24/3243430/24603/en/Repligen-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Provides-2026-Financial-Guidance.html

    GLOBENEWSWIRE
    24 Feb 2026
    Share Share
    Repligen to Report Q4 and Full Year 2025 Financial Results
    Repligen to Report Q4 and Full Year 2025 Financial Results

    10 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/10/3235198/24603/en/Repligen-to-Report-Fourth-Quarter-and-Full-Year-2025-Financial-Results.html

    GLOBENEWSWIRE
    10 Feb 2026
    Share Share
    Repligen Chair Tony Hunt To Retire; Dr. Martin D. Madaus Elected
    Repligen Chair Tony Hunt To Retire; Dr. Martin D. Madaus Elected

    06 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/06/3213498/24603/en/Repligen-Executive-Chair-Tony-Hunt-to-Retire-Dr-Martin-D-Madaus-Elected-Chair.html

    GLOBENEWSWIRE
    06 Jan 2026
    Share Share
    Repligen To Present At J.P. Morgan 2026 Healthcare Conference
    Repligen To Present At J.P. Morgan 2026 Healthcare Conference

    18 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/18/3207603/24603/en/Repligen-Corporation-to-Present-at-J-P-Morgan-2026-Healthcare-Conference.html

    GLOBENEWSWIRE
    18 Dec 2025
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Repligen Corporation and get a quotation

    Repligen Corporation is a supplier offers 8 products (APIs, Excipients or Intermediates).

    Find FAST FLOW IMMOBILIZED RECOMBINANT PROTEIN A IN MASSACHUSETTS bulk offered by Repligen Corporation

    Find ULTRAPURE RECOMBINANT PROTEIN A bulk offered by Repligen Corporation

    Find IMMOBLIZED (R) PROTEIN (A) TM, IPA-500 bulk offered by Repligen Corporation

    Find THERAPEUTIC RECOMBINANT PROTEIN A bulk offered by Repligen Corporation

    Find FACILITIES LOCATED IN CAMBRIDGE, MA bulk offered by Repligen Corporation

    Find IMMOBILIZED PROTEIN A IPA-400HC bulk offered by Repligen Corporation

    Find IMMOBILIZED RECOMBINANT PROTEIN A bulk offered by Repligen Corporation

    Find RG2133(TRIACETYL URIDINE) DRUG SUBSTANCE bulk offered by Repligen Corporation

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search